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Many malignancies that occur in high excess in kidney transplant recipients (KTRs) are
due to viruses that thrive in the setting of immunosuppression. Keratinocyte carcinoma
(KC), the most frequently occurring cancer type in KTR, has been associated with
skin infection by human papillomavirus (HPV) from the beta genus. In this report, we
extend our previous investigation aimed at identifying the presence of active β-HPV
infection in skin tumors from KTRs through detection of viral protein expression. Using a
combination of antibodies raised against the E4 and L1 proteins of the β-genotypes,
we were able to visualize infection in five tumors [one keratoacanthoma (KA), three
actinic keratoses (AKs), and one seborrheic keratoses (SKs)] that were all removed from
two patients who had been both transplanted twice, had developed multiple KCs, and
presented with a long history of immunosuppression (>30 years). These infected tissues
displayed intraepidermal hyperplasia and increased expression of the 1Np63 protein,
which extended into the upper epithelial layers. In addition, using a xenograft model
system in nude mice displaying a humanized stromal bed in the site of grafting, we
successfully engrafted three AKs, two of which were derived from the aforementioned
KTRs and displayed β-HPV infection in the original tumor. Of note, one AK-derived
xenograft, along with its ensuing lymph node metastasis, was diagnosed as squamous
cell carcinoma (SCC). In the latter, both β-HPV infection and 1Np63 expression were
no longer detectable. Although the overall success rate of engrafting was very low, the
results of this study show for the first time that β-HPV+ and 1Np63+ intraepidermal
hyperplasia can indeed progress to an aggressive SCC able to metastasize. Consistent
with a series of reports attributing a causative role of β-HPV at early stages of skin
carcinogenesis through 1Np63 induction and increased keratinocytes stemness, here
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we provide in vivo evidence that these events are also occurring in the affected skin of
KTRs. Due to these β-HPV-driven molecular pathways, the nascent tumor cell is able to
acquire a high enough number of carcinogenic insults that its proliferation and survival
will eventually become independent of viral gene expression.
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INTRODUCTION
The prolonged use of immunosuppressive drugs in kidney
transplant recipients (KTRs) is a recognized risk factor
for infectious diseases and ensuing complications, including
infection-related malignancies (Vajdic and van Leeuwen, 2009;
Krynitz et al., 2013; Geissler, 2015). Keratinocyte carcinoma
(KC), which includes basal cell carcinoma (BCC) and squamous
cell carcinoma (SCC), is the most frequent cancer type in KTRs,
with an incidence rate ranging from 10 to 30% at 10 years
post-transplantation (Kovach and Stasko, 2009; Madeleine et al.,
2012).
Cutaneous human papillomaviruses (HPVs) from the
β-genus, such as HPV5 and HPV8, have long been associated
with KC in patients with a specific genetic background and
in long-term immunosuppressed individuals (Genders et al.,
2015; Howley and Pfister, 2015; Quint et al., 2015). Currently,
more than 200 different HPV types have been described,
which can be clustered into five genera (i.e., alpha-, beta-,
gamma-, mu- and nu-papillomavirus) based on their taxonomy
(http://pave.niaid.nih.gov/#home) (Bernard, 2013; Hufbauer
and Akgül, 2017; Tommasino, 2017). Among them, mucosal
α-genus HPV types are able to infect both oral and genital
mucosa epithelia and are generally ranked as low-risk and
high-risk types according to the tendency of the resulting
neoplasm to undergo malignant progression (Kranjec and
Doorbar, 2016). On the other hand, cutaneous HPVs, which
are clustered in the evolutionarily distinct β-genus, can cause
widespread unapparent or asymptomatic infections in the
general population (Howley and Pfister, 2015; Quint et al., 2015).
However, in immunosuppressed patients and in individuals
suffering from the rare inherited disease epidermodysplasia
verruciformis (EV), these viruses can spread unchecked and
promote the development of KC. For example, β-HPV-associated
wart-like lesions in EV patients are at high risk for progression to
KC (Borgogna et al., 2012; Landini et al., 2014), and the ensuing
tumors are positive for β-HPV DNA and protein expression
(Dell’Oste et al., 2009).
Unlike cancers associated with mucosal HPV infections,
cutaneous HPV-associated KC arisesmainly in sun-exposed body
areas, and hence these viruses are thought to cooperate with
UV to induce cancer (Bouwes Bavinck et al., 2010, 2017; Quint
et al., 2015). A series of reports have indeed demonstrated that
expression of either β-HPV5 or 8 E6 substantially increases the
mutagenic potential of UVB exposure (Wallace et al., 2012). For
example, HPV8 E2, E6, and E7 each have oncogenic activities
when expressed in basal epithelial cells of transgenic mice
(Schaper et al., 2005; Pfefferle et al., 2008; Marcuzzi et al.,
2009; Heuser et al., 2016). Furthermore, β-HPV E6s can alter
Notch-mediated keratinocyte differentiation, thereby fostering a
cellular environment conducive to viral replication (Meyers et al.,
2013; Wallace and Galloway, 2014).
Although recent publications have, for the most part,
characterized in vitro the effects of β-HPV oncogenes on host
signaling pathways, it has become increasingly apparent that the
dissection of the mechanisms underlying viral pathogenesis and
oncogenesis in the affected skin areas during long-term HPV
persistence would further our understanding of how such tissues
are primed for cancer progression. Unfortunately, the exquisite
host specificity of HPVs, which prevents experimental infections
of heterologous hosts, has so far hindered the development
of tractable animal models of infection. Moreover, it appears
that β-HPV sequences are not essential for the maintenance of
the transformed state as they are apparently lost from cancer
cells, especially in non-EV tumors, at later stages of disease
(Weissenborn et al., 2005).
In an effort to correlate β-HPV infection with disease
pathology during progression of premalignant lesions to KC, we
have set up an immunofluorescence protocol that allows both
visualization of productive HPV infection in affected skin areas
and evaluation of skin homeostasis through detection of the
minichromosome maintenance complex component 7 (MCM7),
a cellular proliferation marker (Borgogna et al., 2012, 2014).
Using this protocol, in a previous study of a single center
KTR cohort (Borgogna et al., 2014), we could observe active
β-HPV infection in hyperplastic edges of skin SCC and BCC
as well as in premalignant lesions, such as actinic keratoses
(AK). Of note, while the E4+ areas were mainly found within
the disorganized epithelium of AK lesions, in more advanced
tumors, such as skin SCC and BCC, they were always localized in
the adjacent pathological epithelium. Furthermore, we detected
MCM7 expression extending into the upper epithelial layers
of E4 expressing areas (E4+), indicating that epithelial cells
were actively proliferating in areas of productive viral infection.
Thus, based on these findings, we hypothesized that β-HPV-
induced basal cell proliferation in the immunosuppressed setting
alongside other transforming agents, such as UVB irradiation,
might play a causative role at early stages of neoplastic
transformation, while it may not be necessarily involved at later
stages of the disease (Quint et al., 2015).
Emerging evidence also indicates that β-HPV can perturb p63
expression, a master regulator of development and maintenance
of multilayered epithelia, including the epidermis (Meyers et al.,
2013; Marthaler et al., 2017). p63, predominantly the 1Np63
isoform, is selectively distributed in basal cells of stratified
epithelia where it is required for the replenishment of stem
cells (Senoo et al., 2007; Romano et al., 2009; Koster, 2010;
Melino et al., 2015). In this regard, we have recently shown
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that HPV8-induced field cancerization in a transgenic mouse
model is due to Lrig1+ keratinocyte stem cell expansion, which is
accompanied by aberrant nuclear p63 expression in the expanded
infundibulum and adjoining interfollicular epidermis. EV and
non-EV keratoses displayed similar histology associated with β-
HPV reactivation and nuclear p63 expression (Lanfredini et al.,
2017).
In this study, we have further extended our previous analysis
of a single center cohort of KTRs by (i) analyzing 128
additional skin lesions excised from 29 KTRs; (ii) correlating
1Np63 expression levels with those of E4 and MCM7 in skin
areas of productive HPV infection; and (iii) establishing and
characterizing patient-derived xenografts as models to study skin
cancer progression of β-HPV-infected skin lesions. In particular,
we provide evidence of two KTRs with multiple β-HPV+ skin
tumors and demonstrate progression of a β-HPV+ AK lesion into
SCC in a patient-derived xenograft.
MATERIALS AND METHODS
Sample Collection
Tissue sections were obtained from 171 formalin-fixed and
paraffin-embedded blocks (FFPE) corresponding to either the
core or the edges of the tumor, collected from 128 skin lesions
excised from 29 KTRs attending the dermatology unit in the
University Hospital-Novara. Thirty-two tumors were derived
from KTRs already described in our previous work (patients 1M,
3M, 9M, 14M, 15M, and 17M respectively; Borgogna et al., 2014).
The study was approved by the local ethic committee:
Comitato Etico Interaziendale Novara (Prot. CE 168/15) and
written informed consent was obtained by all subjects according
to the Declaration of Helsinki.
Transplantation of Human Skin Tumors
The immunodeficient mice used for xenograft development were
male athymic Nude-Foxn1nu (Envigo, Huntingdon, UK). Mice
were housed under pathogen-free conditions in our animal
facilities in accordance with The Guide for the Care and Use
of Laboratory Animals and the experimentation was approved
by the CESAPO (Comitato Etico Sperimentazione Animale
Piemonte Orientale, Prot. 20093). Mice were anesthetized with
an Ohmeda TEC4 Vaporizer using Isoflurane Vet (Merial,
Ingelheim am Rhein, Germany) and Gelfoam dressing (Johnson
& Johnson, New Brunswick, NJ) was implanted into the dorsal
sub-cutaneous space together with primary human fibroblasts
suspended in 100 µl Matrigel (BD Biosciences, Milano, Italia),
and wounds were closed with surgical stitches (Ethicon,
Johnson & Johnson, New Brunswick, NJ). After 14 days, mice
were anesthetized and human skin tumors (∼0.5 cm3) were
xenografted into the stromal bed together with 106 primary
human fibroblasts suspended in 100 µl Matrigel (Patel et al.,
2012). Xenograft growth was weekly monitored by measuring
the longer diameter of the tumor mass by caliper. After 3 or 6
months, mice were sacrified via CO2 inhalation and tumors were
removed: half of themwas fixed in 10% neutral-buffered formalin
and embedded in paraffin blocks, while the other half was snap
frozen and stored at−80◦C. Five-µm sections were cut from the
FFPE blocks and stained with hematoxylin and eosin (H&E) as
performed for human skin biopsies.
HPV Genotyping
Total DNA was extracted from the frozen xenograft or plucked
hair bulbs from eyebrows using QIAamp DNA Mini Kit
following the manufacturer’s instructions (Qiagen, Milan, Italy).
β-HPV DNA analysis was carried out using broad spectrum PCR
(PM-PCR) in combination with a reverse hybridization system
[RHA Kit Skin (beta) HPV (Diassay, Rijswijk, the Netherlands)]
as previously described (de Koning et al., 2006).
Immunofluorescence Labeling
DNA-FISH and immunofluorescence detection of β-HPV E4,
MCM7, β-HPV L1 were performed on formalin-fixed and
paraffin-embedded skin biopsies or xenografts using standard
techniques as previously described (Borgogna et al., 2012, 2014).
Briefly, DNA-FISH was performed using as probe the complete
biotin-labeled (Biotin-nick translation kit, Roche Diagnostics
GmbH, Mannheim, Germany) genomic HPV plasmid DNA
(100 ng/ml). For the other markers analyzed (β-HPV E4, MCM7,
β-HPV L1, and 1Np63), antigen unmasking was performed
by heating the slides in a conventional decloaking chamber for
10min at 121◦C in 10mM citrate buffer at pH 6.0 (Vector
Laboratories, Burlingame, CA, USA). Immunofluorescence was
carried out using the following antibodies: rabbit anti-β-HPV
E4 (kindly provided by John Doorbar, 1:1,000), mouse anti-
MCM7 (1:200, Neomarkers Fremont, Fremont, CA), rabbit
anti-1Np63 antibody (clone Poly6190) (BioLegend, San Diego,
CA, USA) (1:500) and rabbit anti-β-HPV L1 (1:1,000). Images
were acquired using a digital scanner (Pannoramic MIDI;
3D Histech Kft., Budapest, Hungary). For the assessment of
histological features, the slides analyzed by immunofluorescence
were disassembled and stained with H&E. The production of
polyclonal antibodies to β-HPV E4 (HPV5E4) and β-HPV L1 has
been previously described (Borgogna et al., 2012, 2014). Briefly,
the broad spectrum anti-L1 antibodies were raised against the
highly conserved region between amino acid 200 and 300 of the
L1 protein, while those against the HPV5E4 crossreact with many
genotypes from species 1 only, including HPV8, 14, 20, 24, 25,
and 36.
RESULTS
Visualization of β-HPV Viral Protein
Expression in Skin Tumors from the KTR
Cohort
In our previous work, we had already analyzed 111 FFPE
blocks obtained from 79 skin lesions of 17 patients from a
cohort of KTRs for the presence of active β-HPV infection by
immunostaining with anti-E4 and anti-L1 antibodies. Among
those specimens, we could find E4+ areas in six FFPE blocks from
four patients corresponding to four AK lesions and the adjacent
pathological area of one SCC and one BCC (Table 1). In this
study, we have analyzed 171 additional FFPE blocks from 128
skin lesions excised from 29 KTRs following the same procedure.
Within this second group, two patients, who were not included
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TABLE 1 | Overview of the skin biopsy blocks from the KTR cohort study examined by immunohistochemistry for the presence of β-HPV infection and grouped according
to pathology diagnosis.
Seborrheic
keratoses,
n = 18
Keratoacanthoma,
n = 16
Bowen’s
disease,
n = 3
Actinic
keratoses,
n = 54
Basal cell
carcinoma,
n = 77
Squamous cell
carcinoma,
n = 39
Total
Lesions,
n = 207
FFPE blocks
n = 20
FFPE blocks
n = 21
FFPE blocks
n = 3
FFPE blocks
n = 71
FFPE blocks
n = 107
FFPE blocks
n = 60
Total FFPE
blocks
n = 282
β-HPV-positive lesions 1 1 7 1 1 11
Previous study
(Borgogna et al., 2014)
4 1 1 6
This study 1 1 3 5
The skin biopsies found positive for β-HPV E4 expression in our previous study (Borgogna et al., 2014) and this current one are indicated separately.
in the previous survey, presented with multiple skin lesions some
of which displayed areas of β-HPV infection.
The first case was a female KTR who underwent a second
kidney transplant (KTx) in 2016 due to the failure of her first
one after 25 years. She displayed many flat, reddish papular
lesions widespread in the total body skin as shown by the
representative picture of the forehead (Figure 1A) that were
very much resembled the EV keratoses, and her clinical history
reported the development of many proliferative skin lesions
(>15) in different body sites starting approximately 10 years after
her first kidney transplant, which was carried out in 1980. A total
of 22 FFPE blocks corresponding to the 13 tumors excised from
this patient from 2014 in our hospital, each diagnosed as SCC
(n = 5), BCC (n = 3), AK (n = 2), or keratoacanthoma (KA)
(n = 3), were made available for immunofluorescence analysis.
β-HPV+ areas were found in one KA located on the leg, and in
two AKs located on the hand and the leg (Table 1). As shown
in representative (Figures 1C,D), E4+ cells were clearly evident
in the areas of an AK lesion presenting with hyperkeratosis and
parakeratosis; some of them were trapped in the keratin layers
where L1+ nuclei were also observed (data not shown). The
cellular proliferation marker MCM7, a subunit of DNA helicase,
was more evident in the E4+ area compared with the adjacent
epithelium, and extended to suprabasal layers, indicating that
cells were primed to enter the cell cycle. In the AK found on
the hand, E4 expression was not detected, while nuclei stained
with the β-HPV late capsidic protein (L1) were well evident in
the upper layers of the epithelium where some differentiation
was still occurring, indicating the presence of productive viral
infection (data not shown).
The second case was a male KTR born in 1960 who underwent
kidney transplant twice, with the first one taking place in 1996.
From 2012 onwards, the patient developed five skin cancers
in different body sites diagnosed as BCC (n = 2), AK (n =
2) and seborrheic keratoses (SK; n = 1). Positivity for β-HPV
markers was found in one AK and in the SK removed from the
back and the left forearm, respectively. The virus-positive AK
displayed highly keratotic epithelium with clear signs of β-HPV-
related cytopathic effects (Figures 2A,B). Immunofluorescence
analysis showed large areas of β-HPV E4 expression in the
most superficial layers of the epithelium and increased MCM7
expression in the basal and suprabasal layers (Figure 2C).
Likewise, in the SK we found a large number of E4+ cells
spread throughout the entire lesion as shown in Figures 2E–G.
Consistent with the benign nature of this skin tumor, MCM7
expression in the basal layer was less evident, while it was highly
expressed in the suprabasal cells overexpressing cytoplasmic E4.
These cells located in the mid to upper epithelial layers had likely
re-entered the cell cycle to support viral genome amplification
as E4 expression usually occurs in cells where viral DNA is
replicating.
1Np63 Expression in Skin Tumors
To ascertain whether p63 induction could also be visualized in
virus-positive skin cancers from the KTR cohort, tissue sections
from all the skin lesions excised from the two aforementioned
patients (n = 18) were co-labeled with antibodies against
1Np63 and MCM7. In addition, six skin lesions (SCC n
= 1, BCC n = 1 and AK n = 4) with areas positive
for E4 expression from our previous survey were similarly
analyzed. As depicted in the representative Figure 3 showing
a KTR-derived BCC identified in the first round of screening
(patient 5M, Borgogna et al., 2014), the 1Np63 protein
was highly expressed in the neoplastic area in comparison
with the non-pathological adjoining epithelium (Figure 3D vs.
Figure 3J), and its expression generally overlapped with that
of MCM7 (Figures 3C,I respectively). This staining pattern
was reproducibly observed in the high-grade lesions, including
SCC (n = 6) and BCC (n = 6). Of note, in the adjacent
β-HPV-infected hyperplastic epithelium as determined by E4
staining (Figure 3F),1Np63 expression extended in the middle-
superficial layers, higher than those expressingMCM7, indicating
that 1Np63 was expressed in cells either proliferating or with
a great potential of proliferation although not yet transformed.
A similar pattern of 1Np63 expression was also observed in
the benign SK shown in Figure 2, where it spread across the
entire epithelium despite the fact that MCM7 was restricted to
some cells in the basal layer and some cells in the intermediate
layers (Figures 2G,H). Also in the case of AK (n = 8) and KA
(n= 3),1Np63 expression exceeded that of MCM7 as it was still
detectable in the more superficial nucleated cells. Quantification
of 1Np63 and MCM7 positive cells confirmed the increase
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FIGURE 1 | Histopathological analysis of an actinic keratoses (AK) from a female kidney transplant recipient (KTR). (A) Flat whitish and reddish papular lesions on her
forehead. (B) Hematoxylin and eosin (H&E) staining of a representative tissue section (scale bar: 1,000µm) from one AK lesion on the leg of the patient.
(C) Magnification of the region highlighted by the blue box shown in panel B (scale bar: 100µm). (D) Immunofluorescence staining for beta human papillomavirus
(β-HPV) E4 and minichromosome maintenance complex component 7 (MCM7) (β-HPV E4 in green; MCM7 in red) of the same tissue section shown in (B,C). The
white arrows indicate E4 staining. (E) Immunofluorescence staining for 1Np63 (green) of a serial section. The white dotted line indicates the basal layer. Sections in
(D,E) were counterstained with 4′,6-diamidino-2-phenylindole (DAPI) (blue) to visualize cell nuclei.
in 1Np63+ cells in both β-HPV-infected cells and tumors vs.
non-pathological epithelium (Supplementary Figure 1). In the
case of β-HPV-infected cells, the number of 1Np63+ cells was
significantly higher than that of MCM7+ cells.
Development of Xenografts in Athymic
Nude Mice
A well-established model to study tumor progression and clinical
outcome is represented by patient-derived xenograft (PDX)
models. PDXs are developed by implanting tumor samples
obtained directly from patients in immunodeficient mice. In
this regard, we have previously shown that the creation of a
humanized stromal bed, by first implanting Gelfoam dressing
along with HDF, facilitates primary human skin SCC xenograft
growth in nude mice (Patel et al., 2012).
Thus, we asked whether premalignant skin lesions could be
similarly engrafted so that we could monitor progression or
regression of a lesion that otherwise would be surgically removed
from the patient. For this purpose, we engrafted all skin lesions
available from the cohort study in the period of observation (3
years), including those that clinically appeared as benign and/or
premalignant. From a total of 42 lesions engrafted following
this procedure, we were able to collect 38 xenografts—in four
cases no tumor growth was detected. The main characteristics
of the KTRs whose skin tumors were grafted into nude mice are
shown in Supplementary Table 1, and the histological features of
the tumors are listed in Table 2. At the beginning, tumors were
removed 6 months after the graft (15 out of 38). Following this
timeline, growth was obtained for two BCCs whose xenograft
histology closely mirrored that found in the original tumor. The
human origin of the xenograft tumors was confirmed by staining
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FIGURE 2 | Immunohistochemical staining for β-HPV E4, MCM7, and 1Np63 in one AK lesion (A–D) and one seborrheic keratoses (SK) lesions (E–H) derived from a
male KTR. (A) H&E staining of a representative tissue section (scale bar: 1,000µm) from one AK lesion on the back of the patient. (B) Magnification of the region
highlighted by the blue box shown in A (scale bar: 100µm). (C) Immunofluorescence staining for β-HPV E4 (green) and MCM7 (red) of the same tissue section shown
in (A,B). (D) Immunofluorescence staining for 1Np63 (green) of a serial section. The white dotted line indicates the basal layer. (E) H&E staining of a representative
tissue section (scale bar: 1,000µm) from one SK lesion on the forearm of the patient. (F) Magnification of the region highlighted by the blue box shown in E (scale bar:
50µm). (G) Immunofluorescence staining for β-HPV E4 (green) and MCM7 (red) of the same tissue section shown in (E,F). (H) Immunofluorescence staining for
1Np63 (green) of a serial section. Sections (C,D,G,H) were counterstained with DAPI (blue) to visualize cell nuclei.
with human cytokeratin (data not shown). Unfortunately, all
other cases (n = 13) turned out to be epidermal cysts filled with
cornified material and surrounded by dying epithelial cells. This
pitfall prompted us to shorten the length of the growing period
in nude mice to 3 months. Using this modified timeline, three
out of the 23 skin tumors engrafted gave rise to a tumor mass
with well-defined histological features. Three AKs successfully
grew in nude mice; two of them displayed a growth curve similar
to that of the two BCCs, while one grew faster, especially after
week 8 (Supplementary Figure 2). While the formers xenografts
retained the original histological features, the latter, which was
derived from the aforementioned male KTR, was diagnosed as
SCC along with its ensuing lymph node metastasis (Figure 4).
Although β-HPV markers were well evident in multiple areas of
the original AK (Figures 2A–D), they were no longer detectable
in the SCC, not even by PCR amplification of xenograft total
DNA using broad spectrum primers for beta genotypes (data
not shown, de Koning et al., 2006). This SCC turned out to be
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FIGURE 3 | Immunohistochemical staining for β-HPV E4, MCM7, and 1Np63 in one basal cell carcinoma (BCC) from a KTR (patient 5M, Borgogna et al., 2014).
(A) H&E staining of a representative tissue section (scale bar: 1,000µm). The red square highlights the BCC, the blue square indicates the HPV-infected area in the
adjacent epithelium, and the green square shows non-pathological epithelium. (B,E,H) Magnification of the regions highlighted by the boxes shown in A (B: red
square; E: blue square; H: green square). Scale bar: 100µm. (C,F,I) Serial sections obtained from the same specimens depicted in panels B, E, and H, respectively,
were subject to double staining using antibodies against β-HPV E4 (green) and MCM7 (red). The white arrows indicate E4 staining. (D,G,J) Serial sections obtained
from the same specimens depicted in (B,E,H), respectively, were stained with antibodies against 1Np63 (green). The white dotted line indicates the basal layer. All
sections were counterstained with DAPI (blue) to visualize cell nuclei.
negative for 1Np63 expression by immunohistochemistry (data
not shown), while it was strongly positive for MCM7. From
the same patient, we also implanted the β-HPV+ SK shown in
Figures 2E–H, which failed to grow in nude mice probably due
to its benign nature. One of the two other AKs was from a patient
transplanted in 1995 who had developed three AKs and one
SCC after 20 years of transplantation. In this case, we failed to
detect any viral protein expression in both xenograft and original
tumor as it was the case in all the other skin lesions excised
from this KTR (data not shown). The second AK was from
the KTR female described above (Figure 1). Consistent with the
fact that a documented β-HPV reactivation was reported in the
female patient as well as in her original skin lesion, in this latter
xenograft, we were able to detect in some cells both viral protein
E4 expression and the presence of the HPV5 genome by FISH
(Figure 5). The HPV5 probe was used because this genotype
was detected in plucked hair bulbs from the eyebrows (data not
shown), which are regarded as representative samples of the virus
carriage on a person’s skin. Furthermore, one SCC and one BCC
were engrafted from the same patient, but they failed to grow in
nude mice.
DISCUSSION
In this study, we extend our previous investigation aimed at
identifying the presence of active β-HPV infection in skin tumors
from KTRs through the detection of viral protein expression,
such as E4 and L1 (Borgogna et al., 2014). In this new round
of screening, we found positive staining in five tumors that were
all removed from two patients who had been both transplanted
twice and presented with a long history of immunosuppression
(>30 years). The female patient had developed many skin
cancers (>15) accompanied by the development of a clinical
picture highly resembling that of an EV patient. Consistent with
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TABLE 2 | Histological features of the skin tumors grafted into nude mice, timeline of excision and outcome of xenograft establishment.
No. of tumors (tot: 42) Xenograft excision after Xenograft establishment
3 months 6 months Failure Growth
Squamous cell carcinoma 6 6 0 6
Basal cell carcinoma 16 9 7 14 2 (BCC)
Keratoacanthoma 1 0 1 1
Actinic keratoses 14 6 8 11 - 2 (AK)
- 1 (SCC+
metastasis)
Seborrheic keratoses 5 3 2 5
FIGURE 4 | Histopathological analysis of an AK xenograft derived from the male KTR. (A) Nude mouse in which the xenograft was diagnosed as SCC (green box)
giving rise to a lymph node metastasis (red box). (B,E) Histopathological features (H&E staining) of the lesions corresponding to the boxes highlighted in A (B: SCC; E:
lymph node metastasis). Scale bars: 1,000µm. (C,F) Magnification of the areas highlighted by the white boxes depicted in (B,E). Scale bar 100µm. The black arrows
indicate cells in mitotic phase. (D,G) Immunofluorescence staining for MCM7 (red) of the same tissue section shown in the (C,F) respectively. Sections (D,G) were
counterstained with DAPI (blue) to visualize cell nuclei.
her clinical manifestations revealing diffuse actinic damage on
her forehead and dorsum of the hands, β-HPV viral protein
expression was observed in three skin tumors, corresponding
to two AKs and one KA. Likewise, among the five skin tumors
removed from the othermale patient, one AK and one SK showed
extensive E4 expression.
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According to our previous findings, E4 expression was
mostly detected at early stages of disease, confirming that virus
expansion was taking place in the skin under condition of
prolonged immunosuppression, albeit no longer detectable
in more advanced stages of disease (Borgogna et al., 2012,
2014; Landini et al., 2014). These infected tissues displayed
intraepidermal hyperplasia as demonstrated by histology,
enhanced expression of the MCM7 proliferation marker in
the suprabasal layers, and 1Np63 expression. Intriguingly,
1Np63 protein expression levels were also high in both benign
and premalignant lesions as well as in cells that did not express
MCM7 and, therefore, were not regarded as actively proliferating.
Overall, given the important role of p63 in the proliferation
and maintenance of epidermal stem cells, and a number of
in vitro and in vivo data linking β-HPV infection to 1Np63
upregulation (Lanfredini et al., 2017; Marthaler et al., 2017),
our findings further strengthen the proposed model of β-HPV-
induced skin carcinogenesis in an immunosuppressed setting
through p63 activation and increased keratinocyte stemness.
Consistently, using a novel bitransgenic mouse model where
1Np63 is overexpressed moderately in the basal layer of
stratified epithelia, Devos et al. have recently demonstrated
that overexpression of 1Np63 favors early steps of skin
tumorigenesis (Devos et al., 2017). Development of benign
lesions, such as papilloma, was indeed accelerated following
1Np63 overexpression in a dose-dependent manner in a classical
two-stage chemical carcinogenesis protocol where an increased
number of papilloma was observed.
Emerging evidence clearly indicates that β-HPVs contribute to
skin cancer development at early stages and through molecular
mechanisms that are different from those reported for high-
risk α-types, such as HPV16 and 18 (Howley and Pfister, 2015;
Quint et al., 2015). Our group and others have reported that β-
HPV can increase stemness properties of keratinocytes in both
monolayer cultures of keratinocytes transduced with HPV8 E6
and E7 viral proteins and an HPV8 transgenic mouse model
where the skin-specific transcription of the early region of HPV8
is driven by the K14 promoter (Hufbauer et al., 2013; Lanfredini
et al., 2017). In all these experimental models, as well as in
β-HPV-infected human skin, this increased stemness is always
accompanied by 1Np63 overexpression (Marthaler et al., 2017).
Thus, together with previous reports pointing to a possible
cooperation between E6 expression and UVB exposure in skin
carcinogenesis, our findings provide in vivo evidence that β-
HPV infection might be a co-factor of early stages of skin cancer
progression. This hypothesis is fully compatible with the “hit-
and-run” mechanisms of carcinogenesis, with cutaneous β-HPV
playing an important role for tumor initiation and progression,
but not required for tumor maintenance. Assuming that viral
replication is more active at very early stages of carcinogenesis,
or when lesions are not yet even clinically evident and rarely
removed, it seems reasonable to propose that at later stages of
disease, when lesions require surgical excision, β-HPV infection
is no longer detectable or otherwise restricted to some residual
areas at the edges of the lesion. These assumptions can explain
the low percentage of positivity found in our study. However, the
observed reactivation of β-HPV infection occurring in the skin of
FIGURE 5 | Histopathological analysis of an AK xenograft derived from the
female KTR. (A) H&E staining of a representative sections of the xenograft.
Scale bar 1,000µm. (B,C) H&E staining of two representative areas positive
for the viral markers. Scale bars: 100µm. (D,E) Magnification of the areas
corresponding to the red squares highlighted in the top pictures and
immunostained for β-HPV E4 protein (green, D) and HPV5 DNA (red, E).
Sections (D,E) were counterstained with DAPI (blue) to visualize cell nuclei.
Scale bars: 10µm.
KTRs alongside the demonstration that these viruses can increase
keratinocyte stemness and interfere with the DNA damage
response argues in favor of a model whereby the cooperation
between β-HPV and UVB, which triggers skin carcinogenesis,
is no longer required to maintain the malignant state at later
stages of neoplastic development (Hufbauer and Akgül, 2017;
Lanfredini et al., 2017; Wendel and Wallace, 2017).
Another important aspect of the current study is the
optimization and implementation of a unique xenograft model
system in nude mice (Patel et al., 2012). Thanks to the creation of
a humanized stromal bed in the site of grafting, here we show
that it is possible to obtain xenograft growth also from small
biopsy samples from relatively benign skin lesions such as AKs.
However, the overall success rate of this procedure was very low
as only three out of 14 engrafted AKs grew as PDXs. Furthermore,
we failed to grow any SCCs while two out of the 16 engrafted
BCCs gave rise to a tumor mass with the same histological
features of the original tumor. This low rate of success may be
due to the low proliferating index of the tumor, especially for
the AK, or the size of the engrafted tumor, which in some cases
was small and very likely did not include enough cells with high
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proliferating capacity. Despite these limitations, the results of
this study are extremely exciting because we show for the first
time that β-HPV+ and 1Np63+ intraepidermal hyperplasia can
indeed progress to an aggressive SCC, including metastasis. As
this SCC developed in 12 weeks in a nude mouse, we cannot
rule out that the engrafted AK already harbored small amount
of SCC. Nevertheless, cancer cells were originated from the
infected epithelium that clinically appeared as field cancerization.
Furthermore, the observation that both 1Np63 and β-HPV are
no longer detectable in the SCC suggests that their roles might
be more important at premalignant stages where they likely
cooperate to create an environment conducive to skin cancer
progression.
Overall, the xenografts obtained following our protocol may
prove useful not only in following the fate of each lesion but also
in increasing the availability of biological samples for molecular
investigations, which is generally limited due to surgical removal
of premalignant lesions. In this regard, every effort should be
made by clinicians involved in the daily management of KTRs to
identify patients with clinically evident virus reactivation in the
skin, and as such at increased risk of developing cancer.
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